1114-1115 / 2063
EORTC – 1219-ROG-HNCG
A blind randomized multicenter study of
accelerated fractionated chemo-radiotherapy
with or without the hypoxic radiosensitizer
nimorazole (Nimoral), using a 15 gene
signature for hypoxia in the treatment of
squamous cell carcinoma of the head and
neck
Pr. Vincent Grégoire, Cliniques Universitaires
Saint-Luc, Brussels, Belgium
Pr. Jens Overgaard, Aarhus, Denmark